Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Exscientia AI Limited
AstraZeneca
Imperial College London
University of California, Irvine
Essen Biotech
Essen Biotech
New Phase Ltd.
DualityBio Inc.
Grey Wolf Therapeutics
University of Nebraska
Natera, Inc.
Elephas
Elephas
RenJi Hospital
Massive Bio, Inc.
Washington University School of Medicine
EtiraRx Australia Pty Ltd
Anhui Provincial Hospital
University of California, Irvine
ModeX Therapeutics, An OPKO Health Company
Singlera Genomics Inc.
Second Affiliated Hospital of Guangzhou Medical University
Cancer Support Community, Research and Training Institute, Philadelphia
Kaohsiung Medical University Chung-Ho Memorial Hospital
Hospices Civils de Lyon